← Leaderboards
Brandon Harvey
National Institute On Drug Abuse
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Drug Abuse
Same institution · by research overlap
- Yun Wang$0
- Barry J Hoffer$2,130,252
Others in their field
Top investigators on “Neurons”
- Hongkui Zeng · Allen Institute$106,358,289
- Eric Martin McDade · Washington University$94,632,845
- Ed Lein · Allen Institute$90,858,363
- Randall J Bateman · Washington University$65,841,935
- John Morris · Washington University$65,018,684
- Paul S. Aisen · Cognition Therapeutics, Inc.$58,570,460
Research focus
NeuronsRattusMethamphetamineCollaborationsGenesPublishingAdeno-Associated Viral VectorLaboratoriesRodentNerve DegenerationProteinsMonitorBrainNational Institute Of Drug AbuseCellsTransgenic OrganismsNeurotrophic FactorGene DeliveryAddictionViral VectorBrain-Derived Neurotrophic FactorNeurotoxicityTransgenesCell Culture Techniques
Grant awards (62)
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration$2,685,245
ZIA · FY2025 · DA · contact PI
Microglia, HIV and drugs of abuse$831,995
ZIA · FY2025 · DA · contact PI
Developing rat models of HIV-associated neurotoxicity and neuroinflammation$436,810
ZIA · FY2025 · DA · contact PI
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration$2,765,624
ZIA · FY2024 · DA · contact PI
Microglia, HIV and drugs of abuse$796,168
ZIA · FY2024 · DA · contact PI
Developing rat models of HIV-associated neurotoxicity and neuroinflammation$418,000
ZIA · FY2024 · DA · contact PI
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration$2,062,691
ZIA · FY2023 · DA · contact PI
Microglia, HIV and drugs of abuse$761,883
ZIA · FY2023 · DA · contact PI
Developing rat models of HIV-associated neurotoxicity and neuroinflammation$400,000
ZIA · FY2023 · DA · contact PI
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration$1,765,394
ZIA · FY2022 · DA · contact PI
Microglia, HIV and drugs of abuse$744,003
ZIA · FY2022 · DA · contact PI
Gene Delivery and Addiction$441,349
ZIA · FY2022 · DA · contact PI
Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration$1,593,318
ZIA · FY2021 · DA · contact PI
Microglia, HIV and drugs of abuse$444,759
ZIA · FY2021 · DA · contact PI
Gene Delivery and Addiction$177,035
ZIA · FY2021 · DA · contact PI
Cellular mechanisms of neuronal dysfunction$483,156
ZIA · FY2020 · DA · contact PI
Microglia, HIV and drugs of abuse$444,759
ZIA · FY2020 · DA · contact PI
SARS-CoV-2 viroporins and endoplasmic reticulum dysfunction$131,770
ZIA · FY2020 · DA · contact PI
Gene Therapy And Neurodegeneration$131,770
ZIA · FY2020 · DA · contact PI
Gene Delivery and Addiction$131,770
ZIA · FY2020 · DA · contact PI
Microglia, HIV and drugs of abuse$444,759
ZIA · FY2019 · DA · contact PI
Cellular mechanisms of neuronal dysfunction$422,012
ZIA · FY2019 · DA · contact PI
Gene Delivery and Addiction$140,671
ZIA · FY2019 · DA · contact PI
Gene Therapy And Neurodegeneration$140,671
ZIA · FY2019 · DA · contact PI
Microglia, HIV and drugs of abuse$444,759
ZIA · FY2018 · DA · contact PI
Cellular mechanisms of neuronal dysfunction$232,422
ZIA · FY2018 · DA · contact PI
Gene Delivery and Addiction$139,453
ZIA · FY2018 · DA · contact PI
Gene Therapy And Neurodegeneration$92,969
ZIA · FY2018 · DA · contact PI
Cellular mechanisms of neuronal dysfunction$889,518
ZIA · FY2017 · DA · contact PI
Optogenetics and Transgenic Technology Core$444,759
ZIC · FY2017 · DA · contact PI
Gene Delivery and Addiction$296,506
ZIA · FY2017 · DA · contact PI
Gene Therapy And Neurodegeneration$296,506
ZIA · FY2017 · DA · contact PI
Optogenetics and Transgenic Technology Core$2,092,870
ZIC · FY2016 · DA · contact PI
Optogenetics and Transgenic Technology Core$1,875,639
ZIC · FY2015 · DA · contact PI
Microglia, HIV and drugs of abuse$701,249
ZIA · FY2015 · DA · contact PI
Gene Therapy And Neurodegeneration$467,499
ZIA · FY2015 · DA · contact PI
Gene Delivery and Addiction$233,750
ZIA · FY2015 · DA · contact PI
Optogenetics and Transgenic Technology Core$1,901,064
ZIC · FY2014 · DA · contact PI
Gene Therapy And Neurodegeneration$197,879
ZIA · FY2014 · DA · contact PI
Microglia and drugs of abuse$197,879
ZIA · FY2014 · DA · contact PI
Gene Delivery and Addiction$197,879
ZIA · FY2014 · DA · contact PI
Microglia and drugs of abuse$460,579
ZIA · FY2013 · DA · contact PI
Optogenetics and Transgenic Technology Core$460,579
ZIC · FY2013 · DA · contact PI
Gene Delivery and Addiction$33,797
ZIA · FY2013 · DA · contact PI
Gene Therapy And Neurodegeneration$33,797
ZIA · FY2013 · DA · contact PI
Optogenetics and Transgenic Technology Core$1,717,126
ZIC · FY2012 · DA · contact PI
Microglia and drugs of abuse$297,706
ZIA · FY2012 · DA · contact PI
Gene Delivery and Addiction$273,270
ZIA · FY2012 · DA · contact PI
Gene Therapy And Neurodegeneration$273,270
ZIA · FY2012 · DA · contact PI
Optogenetics and Transgenic Technology Core$977,493
ZIC · FY2011 · DA · contact PI
Gene Delivery and Addiction$541,554
ZIA · FY2011 · DA · contact PI
Gene Therapy And Neurodegeneration$541,554
ZIA · FY2011 · DA · contact PI
Gene Delivery and Addiction$334,699
ZIA · FY2010 · DA · contact PI
Gene Therapy And Neurodegeneration$334,699
ZIA · FY2010 · DA · contact PI
NeuroAIDS and Viral Vector Core$223,133
ZIC · FY2010 · DA · contact PI
Human genetics and drugs of abuse using the nematode, C. elegans.$223,133
ZIA · FY2010 · DA · contact PI
Gene Delivery and Addiction$282,953
ZIA · FY2009 · DA · contact PI
NeuroAIDS and Viral Vector Core$282,953
ZIC · FY2009 · DA · contact PI
Gene Therapy And Neurodegeneration$188,635
ZIA · FY2009 · DA · contact PI
Gene Delivery and Addiction$497,686
Z01 · FY2008 · DA · contact PI
Gene Therapy And Neurodegeneration$497,686
Z01 · FY2008 · DA · contact PI
Gene Therapy And Neuroprotection$817,880
Z01 · FY2007 · DA · contact PI